- Home
- CELH vs ITCI Comparison
CELH vs ITCI Comparison
Compare CELH & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELH
- ITCI
- Stock Information
- Founded
- CELH 2004
- ITCI 2002
- Country
- CELH United States
- ITCI United States
- Employees
- CELH N/A
- ITCI N/A
- Industry
- CELH Beverages (Production/Distribution)
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- CELH Consumer Staples
- ITCI Health Care
- Exchange
- CELH Nasdaq
- ITCI Nasdaq
- Market Cap
- CELH 8.9B
- ITCI 8.0B
- IPO Year
- CELH N/A
- ITCI N/A
- Fundamental
- Price
- CELH $34.54
- ITCI $76.40
- Analyst Decision
- CELH Strong Buy
- ITCI Strong Buy
- Analyst Count
- CELH 16
- ITCI 11
- Target Price
- CELH $58.60
- ITCI $93.55
- AVG Volume (30 Days)
- CELH 5.3M
- ITCI 462.3K
- Earning Date
- CELH 11-05-2024
- ITCI 10-31-2024
- Dividend Yield
- CELH N/A
- ITCI N/A
- EPS Growth
- CELH N/A
- ITCI N/A
- EPS
- CELH 1.02
- ITCI N/A
- Revenue
- CELH $1,489,877,000.00
- ITCI $564,526,000.00
- Revenue This Year
- CELH $17.90
- ITCI $46.60
- Revenue Next Year
- CELH $18.34
- ITCI $37.06
- P/E Ratio
- CELH $32.34
- ITCI N/A
- Revenue Growth
- CELH 56.50
- ITCI 54.31
- 52 Week Low
- CELH $31.55
- ITCI $45.50
- 52 Week High
- CELH $99.62
- ITCI $84.89
- Technical
- Relative Strength Index (RSI)
- CELH 36.66
- ITCI 55.99
- Support Level
- CELH $32.04
- ITCI $73.05
- Resistance Level
- CELH $34.10
- ITCI $76.34
- Average True Range (ATR)
- CELH 1.75
- ITCI 1.64
- MACD
- CELH 0.16
- ITCI 0.27
- Stochastic Oscillator
- CELH 27.86
- ITCI 86.44
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages (including those that are naturally caffeinated with stevia), Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.